Liquid filter for efficient management of bio-burdens and particles with a filtration precision of 0.2 μm!
The Supor(R) EAV filter ensures high processing capacity and flow rate in the filtration of buffers and bioprocess fluids. 【Features】 - Achieves a more compact and economical filtration system through a narrow core design with a smaller core diameter and the adoption of asymmetric membrane technology in a laid-over pleat structure. - Guarantees excellent microbial filtration efficiency in processes where the bioburden can fluctuate, with a removal efficiency of Brevundimonas diminuta exceeding 6 LRV. *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
Bio-burden management filters can be used for the following applications: - Preparation of media, buffers, and reagents - Debris removal after clarification with depth filters and before purification processes - Intermediates and column guards in purification processes - Buffer adjustments for chromatography and buffer exchanges Depending on the need for validation, filtration sterilization grade filters such as Supor EX ECV filters or Supor EKV filters can also be used for bio-burden management. *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
Company information
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.
